Idelalisib Interactions
There are 861 drugs known to interact with idelalisib, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 225 are major, 620 are moderate, and 16 are minor.
- View all 861 medications that may interact with idelalisib
- View idelalisib alcohol/food interactions (1)
- View idelalisib disease interactions (7)
Most frequently checked interactions
View interaction reports for idelalisib and the medicines listed below.
- Adakveo (crizanlizumab)
- Align (bifidobacterium infantis)
- Alvesco (ciclesonide)
- Amitiza (lubiprostone)
- Aranesp (darbepoetin alfa)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Azithromycin Dose Pack (azithromycin)
- B-12 (cyanocobalamin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Belsomra (suvorexant)
- Botox (onabotulinumtoxinA)
- Breo Ellipta (fluticasone / vilanterol)
- Caprelsa (vandetanib)
- Celebrex (celecoxib)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Contrave (bupropion / naltrexone)
- Dificid (fidaxomicin)
- Droxia (hydroxyurea)
- Endocet (acetaminophen / oxycodone)
- Engerix-B Pediatric (hepatitis b pediatric vaccine)
- Euthyrox (levothyroxine)
- Eutroxsig (levothyroxine)
- Evrysdi (risdiplam)
- Gazyva (obinutuzumab)
- Givlaari (givosiran)
- Hizentra (immune globulin subcutaneous)
- Metoprolol Tartrate (metoprolol)
- Vitamin D3 (cholecalciferol)
Idelalisib alcohol/food interactions
There is 1 alcohol/food interaction with idelalisib.
Idelalisib disease interactions
There are 7 disease interactions with idelalisib which include:
- colitis
- dermatologic toxicities
- hepatic impairment
- infections
- intestinal perforation
- neutropenia
- lung toxicity
More about idelalisib
- idelalisib consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.